Prescription Drug Advertising: Is it Time For a Change?

The public is bombarded with direct-to-consumer (DTC) prescription drug advertising from many different types of media. DTC drug advertising has become a controversial issue with some officials proposing that they be eliminated. The FDA regulates DTC prescription drug advertising with a focus on ensuring that risks are disclosed and preventing the dissemination of false and misleading claims. The advent of radio and TV advertising required modifications to regulations on drug promotion, and modern communication methods, especially the internet, have introduced newer challenges for regulators. This activity will describe the evolution of DTC regulation and discuss ongoing efforts to meet the challenges.